Valderas JM, Starfi B, Sibbald B. Understanding health and health services. Ann Fam Med. 2009;7(4):357–63.
Article
PubMed
PubMed Central
Google Scholar
Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel J-P, et al. The world report on ageing and health: a policy framework for healthyageing. Lancet. 2016;387(10033):2145–54.
Article
PubMed
Google Scholar
Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery A. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011;61(582):e12–21.
Article
PubMed
Google Scholar
Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10(4):430–9.
Article
PubMed
Google Scholar
Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9(7):3–11.
Article
CAS
Google Scholar
Guthrie B, Payne K, Alderson P, McMurdo MET, Mercer SW. Adapting clinical guidelines to take account of multimorbidity. BMJ. 2012;345:e6341.
Article
PubMed
Google Scholar
Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? systematic review of definitions. BMC Geriatr. 2017;17:230.
Article
PubMed
PubMed Central
Google Scholar
Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015;71(12):1415–27.
Article
PubMed
Google Scholar
Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65.
Article
PubMed
Google Scholar
Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345–51.
Article
PubMed
Google Scholar
Ren R, Deng L, Xue Y, Suzuki K, Zhang W, Yu Y, et al. Visualization of aging-associated chromatin alterations with an engineered TALE system. Cell Res. 2017;27(4):483–504.
Article
PubMed
PubMed Central
CAS
Google Scholar
Corsonello A, Pedone C, Incalzi R. Age-related pharmacokinetic and Pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem. 2010;17(6):571–84.
Article
CAS
PubMed
Google Scholar
Poulose N, Raju R. Aging and injury: alterations in cellular energetics and organ function. Aging Dis. 2014;5(2):101–8.
PubMed
PubMed Central
Google Scholar
Rankin A, Cadogan CA, Patterson SM, Kerse N, Cardwell CR, Bradley MC, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;9:CD008165.
PubMed
Google Scholar
Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, Poblador-Plou B, Van Den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. 2014;67(3):254–66.
Article
PubMed
Google Scholar
Guisado-Clavero M, Violán C, López-Jimenez T, Roso-Llorach A, Pons-Vigués M, Muñoz MA, et al. Medication patterns in older adults with multimorbidity: a cluster analysis of primary care patients. BMC Fam Pract. 2019;20(1):1–12.
Article
Google Scholar
Aoki T, Yamamoto Y, Ikenoue T, Onishi Y, Fukuhara S. Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population. Sci Rep. 2018;8(1):3806.
Article
PubMed
PubMed Central
CAS
Google Scholar
Calderón-Larrañaga A, Gimeno-Feliu LA, González-Rubio F, Poblador-Plou B, Lairla-San José M, Abad-Díez JM, et al. Polypharmacy patterns: Unravelling systematic associations between prescribed medications. PLoS One. 2013;8(12):e84967.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kostev K, Jacob L. Multimorbidity and polypharmacy among elderly people followed in general practices in Germany. Eur J Intern Med. 2018;55:66–8.
Article
PubMed
Google Scholar
Violán C, Fernández-Bertolín S, Guisado-Clavero M, Foguet-Boreu Q, Valderas JM, Vidal J, et al. Longitudinal multimorbidity patterns in elderly population using hidden Markov models: a cohort study of Mediterranean elderly population. Sci Rep.
Statistical Institute of Catalonia. Idescat. Statistical Yearbook of Catalonia [Internet]. 2016 [cited 2019 Dec 9]. Available from: http://www.idescat.cat/pub/?id=aec&lang=en.
Memòria d’activitats 2012. Institut Català de la Salut [Internet]. 2012 [cited 2019 Nov 18]. Available from: http://ics.gencat.cat/ca/detall/publicacio/memoria_2012-00007.
García-Gil M, Hermosilla E, Prieto-Alhambra D, Fina F, Rosell M, Ramos R, et al. Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inform Prim Care. 2011;19(3):135–45.
Google Scholar
Calderón-Larrañaga A, Vetrano DL, Onder G, Gimeno-Feliu LA, Coscollar-Santaliestra C, Carfí A, et al. Assessing and measuring chronic multimorbidity in the older population: a proposal for its operationalization. J Gerontol - Ser A Biol Sci Med Sci. 2017;72(10):1417–23.
Google Scholar
WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. 16th ed. Oslo: 2013. https://www.whocc.no/filearchive/publications/1_2013guidelines.pdf.
Elorza-Ricart JM, Tovillas-Morán FJ, Oliveras-Puig A, Galcerán JM, Fina F, Dalfó-Baqué A. Estudio transversal comparativo de las fórmulas CKD-EPI y MDRD-4 a partir de la historia clínica informatizada de Atención Primaria de Barcelona. Hipertens y Riesgo Vasc. 2012;29(4):118–29.
Article
Google Scholar
Forns J, Cainzos-Achirica M, Hellfritzsch M, Morros R, Poblador-Plou B, Hallas J, et al. Validity of ICD-9 and ICD-10 codes used to identify acute liver injury: a study in three European data sources. Pharmacoepidemiol Drug Saf. 2019;28(7):965–75.
Article
CAS
PubMed
PubMed Central
Google Scholar
Domínguez-Berjón MF, Borrell C, Cano-Serral G, Esnaola S, Nolasco A, Pasarín MI, et al. Construcción de un índice de privación a partir de datos censales en grandes ciudades españolas (Proyecto MEDEA). Gac Sanit. 2008;22(3):179–87.
Article
PubMed
Google Scholar
Bezdek JC. Pattern recognition with fuzzy objective function algorithms. 1st ed. New York. Springer: Plenum Press; 1981.
Book
Google Scholar
Rabinier LR. A tutorial on hidden Markov models and selected applications in speech recognition. Proc IEEE. 1989;77(2):257–86.
Article
Google Scholar
White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–99.
Article
PubMed
Google Scholar
Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation making it safe and sound [internet]. London: The King’s Fund; 2013. Available from: https://www.kingsfund.org.uk/sites/default/files/field/field_publication_file/polypharmacy-and-medicines-optimisation-kingsfund-nov13.pdf.
Google Scholar
Cooper JA, Cadogan CA, Patterson SM, Kerse N, Bradley MC, Ryan C, et al. Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open. 2015;5:e009235.
Article
PubMed
PubMed Central
Google Scholar
Morgan DJ, Dhruva SS, Coon ER, Wright SM, Korenstein D. 2018 update on medical overuse. JAMA Intern Med. 2019;179(2):240–6.
Article
PubMed
Google Scholar
Woodford HJ, Barrett S, Pattman S. Vitamin D: too much testing and treating? Clin Med (Northfield Il). 2018;18(3):196–200.
Article
Google Scholar
Mata-Cases M, Franch-Nadal J, Real J, Mauricio D. Glycaemic control and antidiabetic treatment trends in primary care centres in patients with type 2 diabetes mellitus during 2007-2013 in Catalonia: a population-based study. BMJ Open. 2016;6(10):4–11.
Article
Google Scholar
Lipska KJ, Yao X, Herrin J, McCoy RG, Ross JS, Steinman MA, et al. Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006-2013. Diabetes Care. 2017;40(4):468–75.
Article
PubMed
Google Scholar
Dreischulte T, Morales DR, Bell S, Guthrie B. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney Int. 2015;88(2):396–403.
Article
CAS
PubMed
Google Scholar
Baigent C, Bhala N, Emberson J, Merhi A, Abramson S, Arber N, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382:769–79.
Article
CAS
PubMed
Google Scholar
Arfè A, Scotti L, Varas-Lorenzo C, Nicotra F, Zambon A, Kollhorst B, et al. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ. 2016;354:i4857.
Article
PubMed
Google Scholar
Bosch JA, Calbé JJ, Calero F, Díaz JM, Diego L, Esmatjes E, et al. Pautes per a l’harmonització del tractament farmacològic de la malalƽa renal crònica. Barcelona: Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS). Departament de Salut. Generalitat de Catalunya; 2016.
Morales ML, Vélez LN, Muñoz M. OG. Hepatotoxicidad: Patrón colestásico inducido por fármacos. Rev Colomb Gastroenterol. 2016;31(1):36–47.
Article
Google Scholar
Tejada F. Hepatotoxicidad por farmacos. Rev Clínica Med Fam. 2010;3(3):177–91.
Google Scholar
Iglesias P, Díez JJ. Thyroid dysfunction and kidney disease. Eur J Endocrinol. 2009;160(4):503–15.
Article
CAS
PubMed
Google Scholar
Morin L, Johnell K, Laroche ML, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289–98.
Article
PubMed
PubMed Central
Google Scholar
Brownlee S, Chalkidou K, Doust J, Elshaug AG, Glasziou P, Heath I, et al. Evidence for overuse of medical services around the world. Lancet. 2017;390:156–68.
Article
PubMed
PubMed Central
Google Scholar
Benetos A, Rossignol P, Cherubini A, Joly L, Grodzicki T, Rajkumar C, et al. Polypharmacy in the aging patient: Management of Hypertension in octogenarians. J Am Med Assoc. 2015;314(2):170–80.
Article
CAS
Google Scholar